Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-12

Clinical Trial Update: Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports activity of regorafenib in combination with chemotherapy in patients with advanced biliary tract cancer across Phase 1 and Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chemotherapy (chemotherapy)
  • Regorafenib (regorafenib)

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Digestive Cancer | Phase 1, Phase 2 | Status: COMPLETED